ACTRN12606000053527撤回不适用
Pilot trial of the tolerability of hypertonic saline when delivered by a high-output nebuliser twice or four times daily to people with Cystic Fibrosis.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Cystic fibrosis, member of RPA Hospital CF Clinic, stable clinical condition (no non-routine antibiotics in the previous 2 weeks), FEV1 >40% pred.
排除标准
- •Unable/unwilling to provide informed consent, major haemoptysis in the previous year, pregnant or lactating, investigational drugs in the previous 30 days. There is no age limit.
研究者
相似试验
招募中
4 期
A randomized controlled trial on hypertonic saline inhalation in patients with nodular-bronchiectatic Mycobacterium avium complex pulmonary diseaseNontuberculous mycobacterial lung diseaseAtypical mycobacterial infection1002844010024970NL-OMON51731Radboud Universitair Medisch Centrum30
已完成
不适用
A pilot study of the effect of a hypertonic saline/dextran solution compared to mannitol in the management of raised intracranial pressureISRCTN82121210Department of Health
已完成
2 期
Preventive Inhalation of Hypertonic Saline in Infants With Cystic FibrosisCystic Fibrosis Lung DiseaseNCT01619657Heidelberg University42
招募中
4 期
Comparison of the effectiveness of 3% saline nebulization prior to chest physiotherapy over conventional physiotherapy in children with non cystic fibrosis bronchiectasison Cystic Fibrosis BronchiectasisSLCTR/2018/010ady Ridgeway Hospital for Children
已完成
不适用
Tolerability of Inhaled Hypertonic Saline in Infants With Cystic FibrosisCystic FibrosisNCT00546663CF Therapeutics Development Network Coordinating Center19